SLS announcements Sellas Life Sciences Group, Inc. announcements and dividends declared NASDAQ
Sellas Life Sciences Group, Inc. Complete list of announcements declared & dividend announcements by Sellas Life Sciences Group, Inc. SLS
Sellas Life Sciences Group, Inc. SLS listed on NASDAQ and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Sellas Life Sciences Group, Inc. SLS
SELLAS Life Sciences shares plunge 19%: What triggered the sharp sell-off?
SELLAS Life Sciences shares plunged nearly 20% after the biotechnology company priced a 0 million public offering at per share, a discount of around 28% to its previous close. The sell-off followed a sharp rally triggered by positive Phase 3 REGAL t
Announcement as on 20 November 2026
SELLAS Life Sciences Group, Inc. Announces Positive Phase 3 REGAL Trial Results for Galinpepimut-S
SELLAS Life Sciences Group, Inc. issued a press release announcing positive topline results from the pivotal randomized Phase 3 REGAL trial evaluating GPS, an immunotherapeutic cancer vaccine, in patients with AML. The pivotal trial evaluated GPS as mainte
Announcement as on 17 November 2026
SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised)
SELLAS Life Sciences Group (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Announcement as on 31 July 2025
Cantor Fitzgerald Reiterates SELLAS Life Sciences Group (SLS) Overweight Recommendation
Fintel reports that on September 7, 2023, Cantor Fitzgerald reiterated coverage of SELLAS Life Sciences Group (NASDAQ:SLS) with a Overweight recommendation.
Announcement as on 08 September 2023
: Sellas Life Sciences raises million from public offering of stock, warrants
Sellas Life Sciences Group Inc. SLS said Friday that it raised .0 million, through the public sale of common shares and warrants to buy stock. Shares of the biopharmaceutical company, which is focused on cancer treatments, plummeted 43.1% in premarket t
Announcement as on 24 February 2023
Announcements by Sellas Life Sciences Group, Inc. first page | Next page |
SLS Sellas Life Sciences Group, Inc. current price & indicator signals
Recent prices of SLS Sellas Life Sciences Group, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 19 Thu Nov 2026 | 14.86 | 13.35 to 16.54 | -17.21% | 1.62 times |
| 18 Wed Nov 2026 | 17.95 | 17.22 to 21.40 | -6.41% | 1.8 times |
| 17 Tue Nov 2026 | 19.18 | 16.70 to 24.89 | 156.76% | 5.47 times |
| 16 Mon Nov 2026 | 7.47 | 7.24 to 8.39 | -4.96% | 0.32 times |
| 13 Fri Nov 2026 | 7.86 | 7.54 to 9.00 | -2.12% | 0.58 times |
| 12 Thu Nov 2026 | 8.03 | 8.00 to 8.41 | -4.63% | 0.23 times |
| 11 Wed Nov 2026 | 8.42 | 8.08 to 8.59 | 0.6% | 0.2 times |
| 10 Tue Nov 2026 | 8.37 | 8.08 to 8.80 | -2.45% | 0.2 times |
| 09 Mon Nov 2026 | 8.58 | 7.81 to 8.87 | 1.9% | 0.25 times |
| 06 Fri Nov 2026 | 8.42 | 7.14 to 8.42 | 6.85% | 0.4 times |
| 05 Thu Nov 2026 | 7.88 | 7.83 to 9.05 | -13.79% | 0.56 times |
| 04 Wed Nov 2026 | 9.14 | 8.63 to 9.17 | 3.04% | 0.28 times |
Videos related to: SLS announcements Sellas Life Sciences Group, Inc. announcements and dividends declared NASDAQ
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


